X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (870) 870
Publication (137) 137
Book / eBook (26) 26
Book Chapter (11) 11
Patent (8) 8
Web Resource (4) 4
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (361) 361
index medicus (274) 274
female (264) 264
male (245) 245
middle aged (237) 237
aged (225) 225
adult (207) 207
oncology (145) 145
hematology (140) 140
aged, 80 and over (136) 136
cancer (90) 90
prognosis (90) 90
article (85) 85
rituximab (72) 72
treatment outcome (67) 67
lymphomas (65) 65
risk factors (65) 65
young adult (62) 62
adolescent (58) 58
disease-free survival (56) 56
lymphoma (56) 56
research (54) 54
chemotherapy (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
analysis (51) 51
non-hodgkins-lymphoma (49) 49
survival (46) 46
animals (45) 45
survival analysis (43) 43
neoplasm staging (42) 42
care and treatment (41) 41
expression (41) 41
lymphoma, large b-cell, diffuse - drug therapy (40) 40
retrospective studies (40) 40
surgery (39) 39
survival rate (39) 39
b-cell lymphoma (37) 37
hemic and lymphatic diseases (36) 36
abridged index medicus (35) 35
therapy (35) 35
antineoplastic agents - therapeutic use (33) 33
cell biology (33) 33
risk (33) 33
disease (32) 32
cohort studies (31) 31
follow-up studies (31) 31
prospective studies (31) 31
biochemistry & molecular biology (29) 29
genetic aspects (29) 29
non-hodgkin lymphoma (29) 29
case-control studies (27) 27
follicular lymphoma (27) 27
elderly-patients (26) 26
health aspects (26) 26
lymphoma, large b-cell, diffuse - mortality (26) 26
diagnosis (24) 24
medicine & public health (24) 24
medicine, general & internal (24) 24
time factors (24) 24
cyclophosphamide - administration & dosage (23) 23
kaplan-meier estimate (23) 23
lymphoma, large b-cell, diffuse - pathology (23) 23
multivariate analysis (23) 23
age factors (22) 22
epidemiology (22) 22
genetics & heredity (22) 22
medical research (22) 22
mortality (22) 22
patients (22) 22
recurrence (22) 22
united states (22) 22
antibodies, monoclonal - therapeutic use (21) 21
antibodies, monoclonal, murine-derived (21) 21
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
doxorubicin - administration & dosage (21) 21
gene expression (21) 21
non-hodgkin-lymphoma (21) 21
vincristine - administration & dosage (21) 21
genes (20) 20
lymphoma, non-hodgkin - pathology (20) 20
non-hodgkin's lymphomas (20) 20
association (19) 19
genomes (19) 19
genomics (19) 19
immune system diseases (19) 19
immunohistochemistry (19) 19
proteins (19) 19
tumors (19) 19
leukemia (18) 18
medicine, experimental (18) 18
prednisone - administration & dosage (18) 18
proportional hazards models (18) 18
colorectal cancer (17) 17
life sciences (17) 17
lymphoma, large b-cell, diffuse - genetics (17) 17
pathology (17) 17
polymorphism, single nucleotide (17) 17
aneuploidy (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
chemotherapy plus rituximab (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Online Resources - Online (4) 4
Architecture Landscape (Shore + Moffat) - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Not Returned (1) 1
St. Michael's Hospital - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3885 - 3885
Abstract The lymphocyte-to-monocyte ratio at diagnosis (LMR-D) has been reported to be a prognostic factor for clinical outcomes in both T-cell and B-cell... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 813 - 813
Abstract Background: The PI3K/mTORC pathway is upregulated in DLBCL and can be targeted with mTORC1 inhibitors such as everolimus. Everolimus has demonstrated... 
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2015, Volume 21, Issue 8, pp. 922 - 926
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3272 - 3278
Purpose This study sought to characterize transformation incidence and outcome for patients with follicular lymphoma (FL) in a prospective observational series... 
SURVIVAL | DIAGNOSIS | ONCOLOGY | REFRACTORY LOW-GRADE | HIGH-DOSE THERAPY | RITUXIMAB | NON-HODGKINS-LYMPHOMA | I-131 TOSITUMOMAB | INDOLENT | HISTOLOGICAL TRANSFORMATION | CHEMOTHERAPY | ORIGINAL REPORTS | Hema10
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 3007 - 3015
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 844 - 844
Abstract T cell lymphoma (TCL) is a heterogeneous group of malignant lymphomas and is subdivided in three major subgroups, (i) cutaneous (mycosis fungoides... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 3, pp. 251 - 257
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 205 - 205
Abstract Purpose: The purpose of this study was to examine whether quality of life (QOL) scores at diagnosis predict survival among patients with aggressive... 
Journal Article
Blood, ISSN 0006-4971, 01/2014, Volume 123, Issue 5, pp. 602 - 603
In this issue of Blood, Pfreundschuh et al report that young males treated with rituximab-based immunochemotherapy in contrast to elderly males benefit as much... 
B-CELL LYMPHOMA | YOUNG | CHOP | RANDOMIZED CONTROLLED-TRIAL | HEMATOLOGY | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Lymphoma, Large B-Cell, Diffuse - drug therapy | Humans | Rituximab | Female | Male | Antineoplastic Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use
Journal Article
Nature Medicine, ISSN 1078-8956, 05/2018, Volume 24, Issue 5, pp. 679 - 690
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3272 - 3278
Journal Article
Cancer Cell, ISSN 1535-6108, 06/2013, Volume 23, Issue 6, pp. 826 - 838
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4038 - 4038
BACKGROUND: Historically, one in five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT), a life-threatening... 
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2012, Volume 109, Issue 10, pp. 3879 - 3884
Journal Article